Moreover, galunisertib exhibitedanti-proliferative activity in ex vivo models representing a more physiologicalmodel, signifying that inhibition of TGF-β can exert anti-tumoral effects, whichmight be mediated by the tumor microenvironment28,29. Here, TGFB1 is linked to neoplasm.